Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2015

View Archived Issues

HIV Vaccine Trials Network launches phase I/II trial of prime-boost vaccine

IDRI receives BARDA funding to establish adjuvant hub

E Keppra approved in Japan as monotherapy for partial-onset seizures

Queen Mary University of London and Takeda to develop new gastroenterology therapies

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Anti-IL-23 antibody shows clinical effect in Crohn's disease patients

Vichem Chemie Research discloses new FLT3 inhibitors

Anti-MZGP2 antibodies associated with Crohn's disease phenotypes

Actelion Pharmaceuticals patents new lipoxin receptor agonists

Roche patent reports new fusion proteins for Alzheimer's type dementia

New SHIP-2 inhibitors for diabetes designed by University of Toyama

Merck KGaA discloses multiple kinase inhibitors

Novo Nordisk reports positive results from phase II trial of oral semaglutide in type 2 diabetes

Valeant to acquire Salix Pharmaceuticals

Investigators prepare new anti-GARP MAbs

Allergan patents S1P1 receptor ligands

Sosei acquires Heptares Therapeutics

FDA grants orphan drug status to polidocanol for venous malformations

FDA grants priority review to Rapamune sNDA for lymphangioleiomyomatosis

AB-Biotics collaborates with Derbycare to launch AB-Kolicare in China

Shire completes acquisition of NPS Pharmaceuticals

First stem cell-based medicinal product approved in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...